{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Curcumin", "Epilepsy", "Herbal medicine", "Seizure"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34331701", "DateCompleted": {"Year": "2021", "Month": "08", "Day": "03"}, "DateRevised": {"Year": "2021", "Month": "08", "Day": "03"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1007/978-3-030-56153-6_21"], "Journal": {"ISSN": "0065-2598", "JournalIssue": {"Volume": "1291", "PubDate": {"Year": "2021"}}, "Title": "Advances in experimental medicine and biology", "ISOAbbreviation": "Adv Exp Med Biol"}, "ArticleTitle": "Curcumin: A Review of Its Effects on Epilepsy.", "Pagination": {"StartPage": "363", "EndPage": "373", "MedlinePgn": "363-373"}, "Abstract": {"AbstractText": ["Central nervous system (CNS) diseases pose an enormous healthcare burden, at both an individual and a societal level. Epilepsy has now become one of the most prevalent CNS disorders. Pharmaceutical drugs prescribed for epilepsy often have serious side effects and, for this reason, attention has turned to the use of medicinal plants. Curcumin (diferuloylmethane) is a major component of Curcuma longa and exhibits various pharmacological effects, including anti-inflammatory, antioxidant, and immunoregulatory properties. Here, we have reviewed the literature relating specifically to the antiepileptic effects of curcumin. The evidence suggests a protective effect of curcumin in the control of epileptic seizures, together with a protective effect on the relief of memory impairment, which may stem from its influence on monoamine levels in the brain."], "CopyrightInformation": "\u00a9 2021. The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Department of Neuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Forouzanfar", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sabinsa Corporation, East Windsor, NJ, USA."}], "LastName": "Majeed", "ForeName": "Muhammed", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science and Technology, Quchan Branch, Islamic Azad University, Quchan, Iran."}, {"Identifier": [], "Affiliation": "Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Jamialahmadi", "ForeName": "Tannaz", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir."}, {"Identifier": [], "Affiliation": "Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir."}, {"Identifier": [], "Affiliation": "Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland. sahebkara@mums.ac.ir."}], "LastName": "Sahebkar", "ForeName": "Amirhosein", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Adv Exp Med Biol", "NlmUniqueID": "0121103", "ISSNLinking": "0065-2598"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Curcumin"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Epilepsy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Seizures"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2197\u20132223", "ArticleIdList": ["23245608", "23245608", "10.1016/S0140-6736(12)61689-4"]}, {"Citation": "Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J et al (2017) Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology 88(3):296\u2013303", "ArticleIdList": ["27986877", "27986877", "10.1212/WNL.0000000000003509"]}, {"Citation": "McNamara JO (1999) Emerging insights into the genesis of epilepsy. Nature 399(6738 Suppl):A15\u2013A22", "ArticleIdList": ["10392576", "10.1038/399a015", "10392576"]}, {"Citation": "Bialer M, White HS (2010) Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov 9(1):68\u201382", "ArticleIdList": ["20043029", "10.1038/nrd2997", "20043029"]}, {"Citation": "Simonato M (2018) Epilepsy an update on disease mechanisms: the potential role of microRNAs. Front Neurol 9:176. https://doi.org/10.3389/fneur.2018.00176", "ArticleIdList": ["10.3389/fneur.2018.00176", "29615968", "5868323"]}, {"Citation": "L\u00f6scher W, Klitgaard H, Twyman RE, Schmidt D (2013) New avenues for anti-epileptic drug discovery and development. Nat Rev Drug Discov 12(10):757\u2013776", "ArticleIdList": ["24052047", "10.1038/nrd4126", "24052047"]}, {"Citation": "Li JW-H, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325(5937):161\u2013165", "ArticleIdList": ["19589993", "10.1126/science.1168243", "19589993"]}, {"Citation": "Forouzanfar F, Bazzaz BSF, Hosseinzadeh H (2014) Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iran J Basic Med Sci 17(12):929\u2013938", "ArticleIdList": ["25859296", "4387228"]}, {"Citation": "Forouzanfar F, Afkhami Goli A, Asadpour E, Ghorbani A, Sadeghnia HR (2013) Protective effect of Punica granatum L. against serum/glucose deprivation-induced PC12 cells injury. Evid Based Complement Alternat Med 2013:716730. https://doi.org/10.1155/2013/716730", "ArticleIdList": ["10.1155/2013/716730", "23935674", "3723082"]}, {"Citation": "Hosseini A, Forouzanfar F, Rakhshandeh H (2016) Hypnotic effect of nepeta glomerulosa on pentobarbital-induced sleep in mice. Jundishapur J Nat Pharm Prod 11(1). https://doi.org/10.17795/jjnpp-25063"}, {"Citation": "Wang X, Zhang A, Zhou X, Liu Q, Nan Y, Guan Y et al (2016) An integrated chinmedomics strategy for discovery of effective constituents from traditional herbal medicine. Sci Rep 6:18997. https://doi.org/10.1038/srep18997", "ArticleIdList": ["10.1038/srep18997", "26750403", "4707445"]}, {"Citation": "Sadeghnia HR, Shaterzadeh H, Forouzanfar F, Hosseinzadeh H (2017) Neuroprotective effect of safranal, an active ingredient of Crocus sativus, in a rat model of transient cerebral ischemia. Folia Neuropathol 55(3):206\u2013213", "ArticleIdList": ["28984113", "10.5114/fn.2017.70485", "28984113"]}, {"Citation": "Ekor M (2014) The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4:177. https://doi.org/10.3389/fphar.2013.00177", "ArticleIdList": ["10.3389/fphar.2013.00177", "24454289", "3887317"]}, {"Citation": "Forouzanfar F, Hosseinzadeh H, Ebrahimzadeh Bideskan A, Sadeghnia HR (2016) Aqueous and ethanolic extracts of Boswellia serrata protect against focal cerebral ischemia and reperfusion injury in rats. Phytother Res 30(12):1954\u20131967", "ArticleIdList": ["27515127", "10.1002/ptr.5701", "27515127"]}, {"Citation": "Forouzanfar F, Hosseinzadeh H (2018) Medicinal herbs in the treatment of neuropathic pain: a review. Iran J Basic Med Sci 21(4):347\u2013358", "ArticleIdList": ["29796216", "5960749"]}, {"Citation": "Li S, Yuan W, Deng G, Wang P, Yang P, Aggarwal B (2011) Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharm Crops 2:28\u201354", "ArticleIdList": ["10.2174/2210290601102010028"]}, {"Citation": "Gupta SC, Patchva S, Aggarwal BB (2013) Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 15(1):195\u2013218", "ArticleIdList": ["23143785", "10.1208/s12248-012-9432-8", "23143785"]}, {"Citation": "Prasad S, Tyagi AK, Aggarwal BB (2014) Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat 46(1):2\u201318", "ArticleIdList": ["24520218", "3918523", "10.4143/crt.2014.46.1.2"]}, {"Citation": "Gupta SC, Patchva S, Koh W, Aggarwal BB (2012) Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 39(3):283\u2013299", "ArticleIdList": ["22118895", "3288651", "10.1111/j.1440-1681.2011.05648.x"]}, {"Citation": "Prasad S, Gupta SC, Tyagi AK, Aggarwal BB (2014) Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol Adv 32(6):1053\u20131064", "ArticleIdList": ["24793420", "10.1016/j.biotechadv.2014.04.004", "24793420"]}, {"Citation": "Sahebkar A, Serban MC, Ursoniu S, Banach M (2015) Effect of curcuminoids on oxidative stress: a systematic review and meta-analysis of randomized controlled trials. J Funct Foods 18:898\u2013909", "ArticleIdList": ["10.1016/j.jff.2015.01.005"]}, {"Citation": "Abdollahi E, Momtazi AA, Johnston TP, Sahebkar A (2018) Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: a nature-made jack-of-all-trades? J Cell Physiol 233(2):830\u2013848", "ArticleIdList": ["28059453", "28059453"]}, {"Citation": "Panahi Y, Hosseini MS, Khalili N, Naimi E, Majeed M, Sahebkar A (2015) Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis. Clin Nutr 34(6):1101\u20131108", "ArticleIdList": ["25618800", "10.1016/j.clnu.2014.12.019", "25618800"]}, {"Citation": "Saberi-Karimian M, Keshvari M, Ghayour-Mobarhan M, Salehizadeh L, Rahmani S, Behnam B, Jamialahmadi T, Asgary S, Sahebkar A. Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Complement Ther Med. 2020 Mar;49:102322. https://doi.org/10.1016/j.ctim.2020.102322 . Epub 2020 Jan 21. PMID: 32147075."}, {"Citation": "Hasanzadeh S, Read MI, Bland AR, Majeed M, Jamialahmadi T, Sahebkar A. Curcumin: an inflammasome silencer. Pharmacol Res. 2020 Sep;159:104921. doi: 10.1016/j.phrs.2020.104921. Epub 2020 May 25. PMID: 32464325."}, {"Citation": "Abdollahi E, Momtazi AA, Johnston TP, Sahebkar A (2018) Therapeutic effects of curcumin in inflammatory and immunemediated diseases: a nature-made jack-of-all-trades? J Cell Physiol 233(2):830\u2013848"}, {"Citation": "Luis E. Simental-Mend\u00eda, Matteo Pirro, Antonio M. Gotto Jr., Maciej Banach, Stephen L. Atkin, Muhammed Majeed & Amirhossein Sahebkar (2019) Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials, Critical Reviews in Food Science and Nutrition, 59:7, 1178-1187, https://doi.org/10.1080/10408398.2017.1396201"}, {"Citation": "Sahebkar A (2014) Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res 28(5):633\u2013642", "ArticleIdList": ["23922235", "10.1002/ptr.5045", "23922235"]}, {"Citation": "De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB, Mukhopadhyay AK (2009) Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 53(4):1592\u20131597", "ArticleIdList": ["19204190", "2663130"]}, {"Citation": "Karimian MS, Pirro M, Majeed M, Sahebkar A (2017) Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine Growth Factor Rev 33:55\u201363", "ArticleIdList": ["27743775", "10.1016/j.cytogfr.2016.10.001", "27743775"]}, {"Citation": "Teymouri M, Pirro M, Johnston TP, Sahebkar A (2017) Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: a review of chemistry, cellular, molecular, and preclinical features. BioFactors 43(3):331\u2013346"}, {"Citation": "Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mend\u00eda LE, Sahebkar A (2016) Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial. J Cardiovasc Pharmacol 68(3):223\u2013229", "ArticleIdList": ["27124606", "10.1097/FJC.0000000000000406", "27124606"]}, {"Citation": "Panahi Y, Hosseini MS, Khalili N, Naimi E, Simental-Mend\u00eda LE, Majeed M et al (2016) Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: a post-hoc analysis of a randomized controlled trial. Biomed Pharmacother 82:578\u2013582", "ArticleIdList": ["27470399", "10.1016/j.biopha.2016.05.037", "27470399"]}, {"Citation": "Sahebkar A, Cicero AF, Simental-Mend\u00eda LE, Aggarwal BB, Gupta SC (2016) Curcumin downregulates human tumor necrosis factor-\u03b1 levels: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 107:234\u2013242", "ArticleIdList": ["27025786", "10.1016/j.phrs.2016.03.026", "27025786"]}, {"Citation": "Forouzanfar F, Read MI, Barreto GE, Sahebkar A. Neuroprotective effects of curcumin through autophagy modulation. IUBMB Life. 2020 Apr;72(4):652-664. doi: 10.1002/iub.2209. Epub 2019 Dec 5. PMID: 31804772."}, {"Citation": "Bagheri, H., Ghasemi, F., Barreto, G.E., Rafiee, R., Sathyapalan, T., Sahebkar, A. Effects of curcumin on mitochondria in neurodegenerative diseases (2020) BioFactors, 46 (1), pp. 5-20."}, {"Citation": "Cicero AF, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M et al (2017) Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev 75(9):731\u2013767", "ArticleIdList": ["28938795", "10.1093/nutrit/nux047", "28938795"]}, {"Citation": "Momtazi AA, Banach M, Pirro M, Katsiki N, Sahebkar A (2017) Regulation of PCSK9 by nutraceuticals. Pharmacol Res 120:157\u2013169", "ArticleIdList": ["28363723", "10.1016/j.phrs.2017.03.023", "28363723"]}, {"Citation": "Panahi Y, Khalili N, Sahebi E, Namazi S, Reiner \u017d, Majeed M et al (2017) Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial. Complement Ther Med 33:1\u20135", "ArticleIdList": ["28735818", "10.1016/j.ctim.2017.05.006", "28735818"]}, {"Citation": "Mirzaei H, Masoudifar A, Sahebkar A, Zare N, Nahand JS, Rashidi B et al (2017) MicroRNA: a novel target of curcumin in cancer therapy. J Cell Physiol 233(4):3004\u20133015", "ArticleIdList": ["28617957", "10.1002/jcp.26055", "28617957"]}, {"Citation": "Momtazi, A.A., Derosa, G., Maffioli, P., Banach, M., Sahebkar, A. Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases (2016) Molecular Diagnosis and Therapy, 20 (4), pp. 335-345."}, {"Citation": "Mohajeri M, Bianconi V, \u00c1vila-Rodriguez MF, Barreto GE, Jamialahmadi T, Pirro M, Sahebkar A. Curcumin: a phytochemical modulator of estrogens and androgens in tumors of the reproductive system. Pharmacol Res. 2020 Jun;156:104765. doi: 10.1016/j.phrs.2020.104765. Epub 2020 Mar 23. PMID: 32217147."}, {"Citation": "Abbas Momtazi A, Sahebkar A (2016) Difluorinated curcumin: a promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Curr Pharm Des 22(28):4386\u20134397", "ArticleIdList": ["10.2174/1381612822666160527113501"]}, {"Citation": "Rezaee R, Momtazi AA, Monemi A, Sahebkar A (2017) Curcumin: a potentially powerful tool to reverse cisplatin-induced toxicity. Pharmacol Res 117:218\u2013227", "ArticleIdList": ["28042086", "10.1016/j.phrs.2016.12.037", "28042086"]}, {"Citation": "Mohajeri M, Sahebkar A (2018) Protective effects of curcumin against doxorubicin-induced toxicity and resistance: a review. Crit Rev Oncol Hematol 122:30\u201351", "ArticleIdList": ["29458788", "10.1016/j.critrevonc.2017.12.005", "29458788"]}, {"Citation": "Sahebkar A, Henrotin Y (2015) Analgesic efficacy and safety of curcuminoids in clinical practice: a systematic review and meta-analysis of randomized controlled trials. Pain Med 17(6):1192\u20131202", "ArticleIdList": ["26814259", "26814259"]}, {"Citation": "Sahebkar A, Saboni N, Pirro M, Banach M (2017) Curcumin: an effective adjunct in patients with statin-associated muscle symptoms? J Cachexia Sarcopenia Muscle 8(1):19\u201324", "ArticleIdList": ["27897416", "10.1002/jcsm.12140", "27897416"]}, {"Citation": "Keihanian F, Saeidinia A, Bagheri RK, Johnston TP, Sahebkar A (2017) Curcumin, hemostasis, thrombosis and coagulation. J Cell Physiol 233(6):4497\u20134511", "ArticleIdList": ["29052850", "10.1002/jcp.26249", "29052850"]}, {"Citation": "Sahebkar A (2010) Molecular mechanisms for curcumin benefits against ischemic injury. Fertil Steril 94(5):e75\u2013ee6", "ArticleIdList": ["20797714", "10.1016/j.fertnstert.2010.07.1071", "20797714"]}, {"Citation": "Teymouri M, Pirro M, Johnston TP, Sahebkar A (2017) Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: a review of chemistry, cellular, molecular, and preclinical features. BioFactors 43(3):331\u2013346", "ArticleIdList": ["27896883", "10.1002/biof.1344", "27896883"]}, {"Citation": "Iranshahi M, Sahebkar A, Takasaki M, Konoshima T, Tokuda H. Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo. Eur J Cancer Prev. 2009 Sep;18(5):412-5. doi: 10.1097/CEJ.0b013e32832c389e. PMID: 19531956."}, {"Citation": "Mazzolani F, Togni S (2013) Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study. Clin Opthalmol 7:939\u2013945"}, {"Citation": "Allegri P, Mastromarino A, Neri P (2010) Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin Ophthalmol 4:1201\u20131206", "ArticleIdList": ["21060672", "2964958"]}, {"Citation": "Lelli D, Sahebkar A, Johnston TP, Pedone C (2017) Curcumin use in pulmonary diseases: state of the art and future perspectives. Pharmacol Res 115:133\u2013148", "ArticleIdList": ["27888157", "10.1016/j.phrs.2016.11.017", "27888157"]}, {"Citation": "Esmaily H, Sahebkar A, Iranshahi M, Ganjali S, Mohammadi A, Ferns G et al (2015) An investigation of the effects of curcumin on anxiety and depression in obese individuals: a randomized controlled trial. Chin J Integr Med 21(5):332\u2013338", "ArticleIdList": ["25776839", "10.1007/s11655-015-2160-z", "25776839"]}, {"Citation": "Panahi Y, Badeli R, Karami GR, Sahebkar A (2015) Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytother Res 29(1):17\u201321", "ArticleIdList": ["25091591", "10.1002/ptr.5211", "25091591"]}, {"Citation": "Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A et al (2016) Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial. Phytother Res 30(9):1540\u20131548", "ArticleIdList": ["27270872", "10.1002/ptr.5659", "27270872"]}, {"Citation": "Amel Zabihi N, Pirro MP, Johnston T, Sahebkar A (2017) Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Curr Pharm Des 23(7):969\u2013982", "ArticleIdList": ["10.2174/1381612822666161010115235"]}, {"Citation": "Dhir A (2012) Pentylenetetrazol (PTZ) kindling model of epilepsy. Curr Protoc Neurosci Unit 9:37. https://doi.org/10.1002/0471142301.ns0937s58", "ArticleIdList": ["10.1002/0471142301.ns0937s58"]}, {"Citation": "Mehla J, Reeta K, Gupta P, Gupta YK (2010) Protective effect of curcumin against seizures and cognitive impairment in a pentylenetetrazole-kindled epileptic rat model. Life Sci 87(19\u201322):596\u2013603", "ArticleIdList": ["20840851", "10.1016/j.lfs.2010.09.006", "20840851"]}, {"Citation": "Agarwal NB, Jain S, Nagpal D, Agarwal NK, Mediratta PK, Sharma KK (2013) Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice. Fundam Clin Pharmacol 27(2):169\u2013172", "ArticleIdList": ["22044441", "10.1111/j.1472-8206.2011.01002.x", "22044441"]}, {"Citation": "Akula KK, Kulkarni S (2014) Effect of curcumin against pentylenetetrazol-induced seizure threshold in mice: possible involvement of adenosine A1 receptors. Phytother Res 28(5):714\u2013721", "ArticleIdList": ["23893477", "10.1002/ptr.5048", "23893477"]}, {"Citation": "Hashemian M, Anissian D, Ghasemi-Kasman M, Akbari A, Khalili-Fomeshi M, Ghasemi S et al (2017) Curcumin-loaded chitosan-alginate-STPP nanoparticles ameliorate memory deficits and reduce glial activation in pentylenetetrazol-induced kindling model of epilepsy. Prog Neuro-Psychopharmacol Biol Psychiatry 79(Pt B):462\u2013471", "ArticleIdList": ["10.1016/j.pnpbp.2017.07.025"]}, {"Citation": "Choudhary KM, Mishra A, Poroikov VV, Goel RK (2013) Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. Eur J Pharmacol 704(1\u20133):33\u201340", "ArticleIdList": ["23461849", "10.1016/j.ejphar.2013.02.012", "23461849"]}, {"Citation": "Kaur H, Bal A, Sandhir R (2014) Curcumin supplementation improves mitochondrial and behavioral deficits in experimental model of chronic epilepsy. Pharmacol Biochem Behav 125:55\u201364", "ArticleIdList": ["25117510", "10.1016/j.pbb.2014.08.001", "25117510"]}, {"Citation": "Kaur H, Patro I, Tikoo K, Sandhir R (2015) Curcumin attenuates inflammatory response and cognitive deficits in experimental model of chronic epilepsy. Neurochem Int 89:40\u201350", "ArticleIdList": ["26190183", "10.1016/j.neuint.2015.07.009", "26190183"]}, {"Citation": "Reeta K, Mehla J, Pahuja M, Gupta YK (2011) Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Pharmacol Biochem Behav 99(3):399\u2013407", "ArticleIdList": ["21641922", "10.1016/j.pbb.2011.05.011", "21641922"]}, {"Citation": "Cavalheiro EA (1995) The pilocarpine model of epilepsy. Ital J Neurol Sci 16(1\u20132):33\u201337", "ArticleIdList": ["7642349", "10.1007/BF02229072", "7642349"]}, {"Citation": "Ezz HSA, Khadrawy YA, Noor NA (2011) The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate. Neurochem Res 36(11):2195\u20132204", "ArticleIdList": ["21751034", "10.1007/s11064-011-0544-9", "21751034"]}, {"Citation": "Khadrawy YA, Sawie HG, Hosny EN (2018) Neuroprotective effect of curcumin nanoparticles against rat model of status epilepticus induced by pilocarpine. J Complement Integr Med 15(3). https://doi.org/10.1515/jcim-2017-0117"}, {"Citation": "Noor NA, Ezz HSA, Faraag AR, Khadrawy YA (2012) Evaluation of the antiepileptic effect of curcumin and Nigella sativa oil in the pilocarpine model of epilepsy in comparison with valproate. Epilepsy Behav 24(2):199\u2013206", "ArticleIdList": ["22575751", "10.1016/j.yebeh.2012.03.026", "22575751"]}, {"Citation": "Du P, Tang HY, Li X, Lin HJ, Peng WF, Ma Y et al (2012) Anticonvulsive and antioxidant effects of curcumin on pilocarpine-induced seizures in rats. Chin Med J 125(11):1975\u20131979", "ArticleIdList": ["22884064", "22884064"]}, {"Citation": "Ahmad M (2013) Protective effects of curcumin against lithium\u2013pilocarpine induced status epilepticus, cognitive dysfunction and oxidative stress in young rats. Saudi J Biol Sci 20(2):155\u2013162", "ArticleIdList": ["23961231", "3730552", "10.1016/j.sjbs.2013.01.002"]}, {"Citation": "L\u00e9vesque M, Avoli M (2013) The kainic acid model of temporal lobe epilepsy. Neurosci Biobehav Rev 37(10 Pt 2):2887\u20132899", "ArticleIdList": ["24184743", "4878897", "10.1016/j.neubiorev.2013.10.011"]}, {"Citation": "Jiang Z, Guo M, Shi C, Wang H, Yao L, Liu L et al (2015) Protection against cognitive impairment and modification of epileptogenesis with curcumin in a post-status epilepticus model of temporal lobe epilepsy. Neuroscience 310:362\u2013371", "ArticleIdList": ["26415768", "10.1016/j.neuroscience.2015.09.058", "26415768"]}, {"Citation": "Gupta YK, Briyal S, Sharma M (2009) Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats. Indian J Physiol Pharmacol 53(1):39\u201346", "ArticleIdList": ["19810575", "19810575"]}, {"Citation": "Sumanont Y, Murakami Y, Tohda M, Vajragupta O, Watanabe H, Matsumoto K (2006) Prevention of kainic acid-induced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin. Life Sci 78(16):1884\u20131891", "ArticleIdList": ["16266725", "10.1016/j.lfs.2005.08.028", "16266725"]}, {"Citation": "Sumanont Y, Murakami Y, Tohda M, Vajragupta O, Watanabe H, Matsumoto K (2007) Effects of manganese complexes of curcumin and diacetylcurcumin on kainic acid-induced neurotoxic responses in the rat hippocampus. Biol Pharm Bull 30(9):1732\u20131739", "ArticleIdList": ["17827730", "10.1248/bpb.30.1732", "17827730"]}, {"Citation": "Willmore LJ, Sypert GW, Munson JB (1978) Recurrent seizures induced by cortical iron injection: a model of posttraumatic epilepsy. Ann Neurol 4(4):329\u2013336", "ArticleIdList": ["103489", "10.1002/ana.410040408", "103489"]}, {"Citation": "Jyoti A, Sethi P, Sharma D (2009) Curcumin protects against electrobehavioral progression of seizures in the iron-induced experimental model of epileptogenesis. Epilepsy Behav 14(2):300\u2013308", "ArticleIdList": ["19100339", "10.1016/j.yebeh.2008.11.011", "19100339"]}, {"Citation": "Reeta K, Mehla J, Gupta YK (2009) Curcumin is protective against phenytoin-induced cognitive impairment and oxidative stress in rats. Brain Res 1301:52\u201360", "ArticleIdList": ["19765566", "10.1016/j.brainres.2009.09.027", "19765566"]}, {"Citation": "Reeta K, Mehla J, Gupta YK (2010) Curcumin ameliorates cognitive dysfunction and oxidative damage in phenobarbitone and carbamazepine administered rats. Eur J Pharmacol 644(1\u20133):106\u2013112", "ArticleIdList": ["20667451", "10.1016/j.ejphar.2010.07.022", "20667451"]}, {"Citation": "Bharal N, Sahaya K, Jain S, Mediratta PK, Sharma KK (2008) Curcumin has anticonvulsant activity on increasing current electroshock seizures in mice. Phytother Res 22(12):1660\u20131664", "ArticleIdList": ["18661468", "10.1002/ptr.2551", "18661468"]}, {"Citation": "Drion CM, Borm LE, Kooijman L, Aronica E, Wadman WJ, Hartog AF et al (2016) Effects of rapamycin and curcumin treatment on the development of epilepsy after electrically induced status epilepticus in rats. Epilepsia 57(5):688\u2013697", "ArticleIdList": ["26924447", "10.1111/epi.13345", "26924447"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "31", "Hour": "12", "Minute": "10"}, {"Year": "2021", "Month": "8", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "4", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34331701", "10.1007/978-3-030-56153-6_21"]}}], "PubmedBookArticle": []}